| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.008 |